奥马珠单抗与肥大细胞疾病：我们做到了吗？ - Suppr

Suppr

超能文献

Omalizumab and Mast Cell Disorders: Are We There Yet?

作者信息

Weiler Catherine R

机构信息

Division of Allergy, Mayo Clinic, Rochester, Minn.

出版信息

J Allergy Clin Immunol Pract. 2019 Sep-Oct;7(7):2396-2397. doi: 10.1016/j.jaip.2019.04.030.

DOI:10.1016/j.jaip.2019.04.030

PMID:31495435

Abstract

摘要

相似文献

Omalizumab and Mast Cell Disorders: Are We There Yet?奥马珠单抗与肥大细胞疾病：我们做到了吗？

J Allergy Clin Immunol Pract. 2019 Sep-Oct;7(7):2396-2397. doi: 10.1016/j.jaip.2019.04.030.

Omalizumab Therapy for Mast Cell-Mediator Symptoms in Patients with ISM, CM, MMAS, and MCAS.奥马珠单抗治疗 ISM、CM、MMAS 和 MCAS 患者的肥大细胞介质症状。

J Allergy Clin Immunol Pract. 2019 Sep-Oct;7(7):2387-2395.e3. doi: 10.1016/j.jaip.2019.03.039. Epub 2019 Apr 5.

The efficacy of omalizumab in Cutaneous Mastocytosis: A case series.奥马珠单抗治疗皮肤肥大细胞增多症的疗效：病例系列研究。

Dermatol Ther. 2019 May;32(3):e12848. doi: 10.1111/dth.12848. Epub 2019 Feb 20.

Omalizumab as a desensitizing agent and treatment in mastocytosis: a review of the literature and case report.奥马珠单抗作为肥大细胞增多症的脱敏剂和治疗药物：文献复习和病例报告。

J Allergy Clin Immunol Pract. 2014 May-Jun;2(3):266-70. doi: 10.1016/j.jaip.2014.03.009.

Effective management of severe cutaneous mastocytosis in young children with omalizumab (Xolair ).奥马珠单抗（Xolair）有效治疗婴幼儿严重皮肤肥大细胞增多症。

Clin Exp Dermatol. 2018 Jul;43(5):573-576. doi: 10.1111/ced.13408. Epub 2018 Feb 16.

Selective Response to Omalizumab in a Patient With Concomitant ncMCAS and POTS: What Does it Teach us About the Underlying Disease?一名合并非遗传性肥大细胞活化综合征（ncMCAS）和体位性心动过速综合征（POTS）患者对奥马珠单抗的选择性反应：它能让我们了解潜在疾病的哪些方面？

J Investig Allergol Clin Immunol. 2018 Aug;28(4):261-263. doi: 10.18176/jiaci.0251.

Omalizumab prevents anaphylaxis and improves symptoms in systemic mastocytosis: Efficacy and safety observations.奥马珠单抗预防全身性肥大细胞增多症的过敏反应和改善症状：疗效和安全性观察。

Allergy. 2018 Jan;73(1):230-238. doi: 10.1111/all.13237. Epub 2017 Jul 27.

Successful treatment of mastocytic anaphylactic episodes with reduction of skin mast cells after anti-IgE therapy.抗IgE治疗后肥大细胞性过敏反应发作得到成功治疗，皮肤肥大细胞数量减少。

Eur Ann Allergy Clin Immunol. 2013 Apr;45(2):52-5.

Omalizumab induced remission of idiopathic anaphylaxis in a patient suffering from indolent systemic mastocytosis.奥马珠单抗使一名患有惰性系统性肥大细胞增多症的患者的特发性过敏反应得到缓解。

Acta Derm Venereol. 2014 May;94(3):363-4. doi: 10.2340/00015555-1687.

Timing of response and long term efficacy of Omalizumab in non-clonal Mast Cell Activation Syndrome: A case series.奥马珠单抗治疗非克隆性肥大细胞活化综合征的反应时机及长期疗效：病例系列

Eur J Intern Med. 2020 Jan;71:104-106. doi: 10.1016/j.ejim.2019.11.010. Epub 2019 Nov 15.

引用本文的文献

Complete relief by omalizumab in eruptive pruritic papular porokeratosis.奥马珠单抗使发疹性瘙痒性丘疹性汗孔角化症完全缓解。

JAAD Case Rep. 2024 Apr 28;49:20-21. doi: 10.1016/j.jdcr.2024.04.030. eCollection 2024 Jul.

Successful treatment with Omalizumab of a child affected by Systemic Mastocytosis: clinical and biological implications.奥马珠单抗成功治疗系统性肥大细胞增多症患儿：临床和生物学意义。

Ital J Pediatr. 2023 Jan 13;49(1):6. doi: 10.1186/s13052-022-01402-7.

Impact of Biologic Therapy on the Small Airways Asthma Phenotype.生物疗法对小气道哮喘表型的影响。

Lung. 2022 Dec;200(6):691-696. doi: 10.1007/s00408-022-00579-2. Epub 2022 Oct 14.

A fully human anti-c-Kit monoclonal antibody 2G4 inhibits proliferation and degranulation of human mast cells.一种完全人源化的抗 c-Kit 单克隆抗体 2G4 可抑制人肥大细胞的增殖和脱颗粒。

Mol Cell Biochem. 2023 Apr;478(4):861-873. doi: 10.1007/s11010-022-04557-3. Epub 2022 Sep 15.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验